Opus Genetics (IRD) Cash from Investing Activities Growth (3y) (2013 - 2024)
Opus Genetics (IRD) Cash from Investing Activities Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Opus Genetics | 291.93 Mn | 231.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 141.59% |
| Dec 31, 2021 | -27.03% |
| Dec 31, 2020 | 29.58% |
| Dec 31, 2019 | -26.54% |
| Sep 30, 2019 | 52.89% |
| Jun 30, 2019 | 6.52% |
| Mar 31, 2019 | -97.40% |
| Dec 31, 2018 | 35.13% |
| Sep 30, 2018 | -19.25% |
| Jun 30, 2018 | 7.22% |
| Mar 31, 2018 | -10.89% |
| Dec 31, 2017 | -11.10% |
| Sep 30, 2017 | 28.99% |
| Jun 30, 2017 | -413.85% |
| Mar 31, 2017 | 190.99% |
| Dec 31, 2016 | 147.31% |
| Sep 30, 2016 | -407.07% |
| Jun 30, 2016 | 85.62% |
| Mar 31, 2016 | -97.63% |
| Dec 31, 2015 | -69.74% |